OpenAlex
PricingAboutJobs
Log inGet started
Work

The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction

HTML

Year: 2020
Type: article
Source: European Journal of Preventive Cardiology
DOI: 10.1177/2047487319896648
Authors: Zanfina Ademi, Richard Ofori-Asenso, Ella Zomer, Alice Owen, Danny Liew
Institution: Monash University
Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life
Subfield: Economics and Econometrics
Field: Economics, Econometrics and Finance
Domain: Social Sciences
Keywords: icosapent ethyl, omega-3 fatty acids, statins, combination therapy, cardiovascular disease prevention, cost-effectiveness, incremental cost-effectiveness ratio, quality-adjusted life years, primary prevention, secondary prevention, health care costs
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2998804962
FWCI: 3.945
Cites: 35
Cited by: 31
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security